Business, Innovation and Value Creation in the Life Science Industry

2019-2020

Course Objective

Business, Innovation and Value Creation in the Life Sciences Industry
(BIV in LSI) aims to meet two distinct teaching and learning goals:
a. To obtain in-depth and comprehensive insight into current business,
innovation and entrepreneurship trends, approaches and state-of-the-art
practice in the LSI through theory, literature and case analysis.
b. To utilize and apply insights and experiences gained under a. in a
personal entrepreneurship case assignment in which each individual
student elects a
target product or service. And develops a business plan for this product
or service according to a
set methodology. Essential parts of this process include: building
strategy, business modeling, transactional
modelling, building a value proposition, assessing investment
requirements, rNPV modelling, leveraging IP, marketing and
commercialization planning.

Course Content

The Life Sciences Industrial landscape is covered in several ways:
1. Understanding the Pharma, Biotech and Health Care sectors and their
primary and secondary drivers, including the role and contribution of
science and technology.
2. Understanding relevant business, value chain and innovation models
that are common in these industries and sectors.
3. Understanding typical product life-cycle dynamics in the Pharma and
Biotech and related Health sectors.
4. Understanding the relative contribution and position of Genomics,
Proteomics and other scientific areas in the future of
Health and Life Sciences
5. Understanding current product categories and future scenarios for
diagnosis, therapy and prevention

In addition to lectures on the above topics, students will be handed
certain texts and articles that illustrate the `State of the Art’ in the
LSI sector from both a product development as well as from a business
development standpoint. As a result the student will get insight into
the business decisions and dynamics that drive
bio-scientific research from product inception through to development
and product commercialization. The course thus aims to provide an
in-depth
overview of how life science and business are interwoven in everyday
industrial practice.

Teaching Methods

A mix of lectures, guest lectures, Pharma sector casework and related
assignments. Individual coaching on the business planning exercise.
Outputs include a report and oral presentations.

Method of Assessment

In order to receive 6 credits for this course, each student must meet
the following criteria: Case work assignment : will be graded on the
following components according a specific rubric as follows: Definition
including idea generation (5% of final grade), Discovery research (10%
ofg), Construct (10% ofg), Outcomes including Report and
Presentations(75% ofg). Where each component must score 6 or higher.
Absence of active participation in class may result in a lower final
grade.

Entry Requirements

Completed Bachelor SBI or comparible

Literature

Selected scientific publications
New World Drug Discovery by R Robert M. Rydzewski 2008
Business Model Generation – Osterwalder 2010

Target Audience

Ma SBI, Ma MPA, Ma Oncology

Additional Information

In case you have any questions about this course, please contact the
coordinator at

General Information

Course Code X_432723
Credits 6 EC
Period P3
Course Level 500
Language of Tuition English
Faculty Faculty of Science
Course Coordinator drs. P. van Hoorn
Examiner drs. P. van Hoorn
Teaching Staff drs. P. van Hoorn
prof. dr. I.J.P. de Esch

Practical Information

You need to register for this course yourself

Last-minute registration is available for this course.

Teaching Methods Lecture
Target audiences

This course is also available as: